Pricing Index · Updated November 4, 2026
Mounjaro Cost in 2026: Brand vs Compounded Tirzepatide
Mounjaro's full pharmacy price is well above $1,000 a month, but few people pay that. Below: LillyDirect self-pay prices, the savings card, branded telehealth program fees ($74 to $599/mo, usually plus the drug), and advertised compounded tirzepatide ($79.60 to $351/mo).
1. Eli Lilly direct pricing
Lilly sells tirzepatide vials and KwikPens self-pay through LillyDirect under the Zepbound label (FDA-approved for chronic weight management), not the Mounjaro label. Prices as of November 4, 2026:
- 2.5 mg vial: $299/mo
- 5 mg vial: $399/mo
- 7.5 mg through 15 mg: $449/mo, provided you refill within 45 days. Otherwise Lilly charges $499 for 7.5 mg and $699 for 10 mg to 15 mg.
Vials require you to draw up and inject each dose with a syringe. Mounjaro itself (the diabetes-indicated single-dose pen) is sold self-pay through LillyDirect starting at $499/mo for every dose from 2.5 mg to 15 mg (checked November 4, 2026). If you have commercial insurance that covers Mounjaro, the separate Mounjaro savings card lets eligible patients pay as little as $25 for up to a 3-month fill. Savings are capped at $150 per 1-month fill and $1,950 per year.
2. Branded tirzepatide programs we track
We track 16 telehealth and clinic programs offering branded tirzepatide (Mounjaro or Lilly Direct). Sorted by monthly cost. Most of these prices are the program or membership fee only. Unless the last column says the drug is included, you pay for the medication separately, through insurance or LillyDirect.
| Provider | Program | $/mo | Insurance | HSA/FSA | Drug included |
|---|---|---|---|---|---|
| WeightWatchers Clinic | WeightWatchers Clinic | $74 | Yes | No | No, fee only |
| Hello Alpha | Weight Loss Plus+ | $79 | Yes | No | No, fee only |
| JumpstartMD | Medical Weight Loss with GLP-1 | $99 | Yes | Yes | No, fee only |
| Sesame | Success by Sesame | $99 | Yes | Yes | No, fee only |
| Everlywell | Weight Care+ | $99 | No | Yes | No, fee only |
| Spartan Medical Associates | GLP-1 Weight Loss | $125 | No | No | No, fee only |
| Mochi Health | Mochi Weight Loss | $139 | Yes | Yes | No, fee only |
| Ro | Body Program | $149 | Yes | Yes | No, fee only |
| LifeMD | GLP-1 Weight Management | $149 | Yes | Yes | No, fee only |
| Genesis Lifestyle Medicine | Medical Weight Loss | $150 | No | Yes | Yes |
| Calibrate | Metabolic Reset | $199 | Yes | Yes | No, fee only |
| Options Medical Weight Loss | GLP-1 Weight Loss | $199 | Yes | Yes | Yes |
| Form Health | Obesity Medicine Program | $299 | Yes | Yes | No, fee only |
| Lemonaid Health | Weight Loss Program | $348 | No | Yes | No, fee only |
| Rivas Medical Weight Loss | GLP-1 Program | $460 | No | Yes | Yes |
| Pallas Health | Brand-Name GLP-1s (Cash-Pay) | $599 | No | Yes | Yes |
See the full pricing index for methodology and CSV download.
3. Compounded tirzepatide alternative
Some providers advertise compounded tirzepatide at lower prices. These products are not FDA-approved, are not generic Mounjaro, and have not been reviewed by FDA for safety, effectiveness, quality, or bioequivalence. We track 43 advertised programs:
Cheapest compounded tirzepatide: Lavender Sky Health at $79.60/mo. See provider profile.
FDA declared the tirzepatide shortage resolved in October 2024, so the shortage-based path for routine copies ended after the 2025 enforcement grace periods. FDA says compounded drugs should be used only when a patient's needs cannot be met by an approved drug. In February 2026 FDA said companies cannot claim compounded products are generics or the same as FDA-approved drugs. Read our guide on brand vs compounded for more.
4. Mounjaro dosing cost ladder
The Mounjaro label starts at 2.5 mg weekly for 4 weeks, then 5 mg, with 2.5 mg steps after at least 4 weeks on a dose, up to 15 mg. LillyDirect charges the same $499/mo at every Mounjaro dose. Its Zepbound vials and KwikPens cover the same six strengths at $299 to $449/mo. Dose changes are your prescriber's call, not a cost decision.
If cost is the problem at higher doses, ask your prescriber about:
- Switching to Zepbound if you qualify for its weight-management label (sold self-pay as vials or KwikPens)
- The manufacturer savings card if you have commercial insurance that covers Mounjaro
- Whether a compounded product is appropriate for you. It is not FDA-approved, and compounded doses and concentrations can differ from the brand, so never convert doses yourself.
5. Insurance and savings programs
Mounjaro is FDA-approved for type 2 diabetes (see the prescribing information). Plans that cover it generally expect that diagnosis. Two paths:
- Diagnosis-based coverage: if you have type 2 diabetes, ask your plan about formulary tier, prior authorization and your copay.
- Mounjaro savings card: commercially insured patients with Mounjaro coverage can pay as little as $25 for up to a 3-month fill, for up to 13 fills per year. Lilly says governmental beneficiaries are excluded. People with commercial insurance that does not cover Mounjaro can pay as low as $499 per 1-month fill.
For weight-loss-only prescriptions, Zepbound (same molecule, different FDA indication) is more likely to be covered.
FAQ
How much does Mounjaro cost without insurance in 2026?
LillyDirect sells Mounjaro pens self-pay starting at $499/mo for every dose (checked November 4, 2026). Zepbound-branded vials and KwikPens run $299 to $449/mo. Branded tirzepatide telehealth programs in our index charge fees of $74 to $599/mo, and most of those fees exclude the drug.
Is compounded tirzepatide cheaper than Mounjaro?
Advertised prices are usually lower. Compounded tirzepatide ranges $79.60 to $351/mo across 43 programs we track, median $196/mo, against $499/mo for Mounjaro through LillyDirect. Compounded tirzepatide is not FDA-approved and is not generic Mounjaro.
Does insurance cover Mounjaro for weight loss?
Mounjaro is FDA-approved for type 2 diabetes, not weight loss, so plans that cover it usually require a diabetes diagnosis. For weight management, Zepbound (same molecule, FDA-approved for obesity) is the label that matches. Whether it is covered depends on your plan's obesity-medication benefits.
What is the cheapest way to get Mounjaro in 2026?
With commercial insurance that covers Mounjaro, the savings card can bring eligible patients to as little as $25 for up to a 3-month fill (savings capped at $150 per month). Without coverage, LillyDirect sells Mounjaro pens at $499/mo, or Zepbound vials and KwikPens at $299 to $449/mo with a Zepbound prescription. Compounded tirzepatide is advertised at $79.60 to $351/mo but is not FDA-approved.
Has Mounjaro been removed from the FDA shortage list?
Yes. FDA announced the tirzepatide shortage was resolved on October 2, 2024 and confirmed it on December 19, 2024. Enforcement discretion for 503A pharmacies ended after a federal court denied a preliminary injunction on March 5, 2025, and the 503B outsourcing facility period ended March 19, 2025.
What we checked
This AI-assisted public-source desk check reviewed LillyDirect's Mounjaro and Zepbound self-pay pages, the Mounjaro savings card terms, the Mounjaro prescribing information and FDA's compounding policy page on November 4, 2026. Telehealth program prices come from our provider data, checked the same day. This is not a clinical review and it is not medical advice. Prices and policies change, so confirm them with the provider or your prescriber before you act.